How many employees does Biovantek have?

As of Dec 31, 2024, the latest employee count at Biovantek is 51 - 200.

Is Biovantek a funded company?

Biovantek is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Biovantek rank among its competitors?

Biovantek ranks 4215th amongst 4315 active competitors, of which 119 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ipsen, which secured $618K in Dec, 2023.

Who are the top competitors of Biovantek?

Biovantek's top competitors include Abbott, WuXi AppTec and ANI Pharmaceuticals. Among them, Ipsen secured the most recent funding round in December, 2023.

Biovantek - 2026 Company Profile & Competitors

Biovantek's employee count trend

Biovantek has 51 - 200 employees as of Dec 24. Here is Biovantek's employee count trend over the years:

Uncover Biovantek's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biovantek include Abbott, WuXi AppTec and ANI Pharmaceuticals. Here is the list of Top 10 competitors of Biovantek, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	Digital Pharma Lab, Castle Investment Management ... & 10 others	80/100
2nd	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
3rd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorgan Chase, Ampersand Capital & 4 others	64/100
4th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	ACE & Company, North Sky Capital & 2 others	63/100
5th	Aptar 1992, Crystal Lake (United States), Public	Provider of regulatory support, brand differentiation, and prototyping services	-	Al Zayani Investments	63/100
6th	Neolife 1958, Fremont (United States), Unfunded	Provider of whole food nutritional supplements	-	-	63/100
7th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, Qualium Investissement ... & 2 others	62/100
8th	Herbalife 1980, Los Angeles (United States), Public	Manufacturer of nutritional supplement products for multiple therapeutic conditions	-	Alua Capital Management, Golden Gate Capital ... & 2 others	61/100
9th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
10th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
4215th	Biovantek Unfunded	-	-	-	16/100